Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Inside information: The Board of Directors of Suominen Corporation has resolved on a fully underwritten rights issue of approximately EUR 28 million and publishes the terms and conditions of the right
-
Elektros Inc. Highlights Progress in Lithium Mining Strategy and EV Charging Patent Discussions as Industry Interest in Electrification Continues to Grow
-
Pampa Medina Sulphide Drilling Intersects 16m of 5.70% Cu and 62.6 g/t Ag including 4m of 11.32% Cu and 144.0 g/t Ag in Significant Extension of UHG Bornite Zone
-
Waterside Recovery Opens New Westborough Location, Expanding Access to Outpatient Addiction Treatment in Massachusetts
-
ViVi Youth Launches Advanced Myo-Inositol & D-Chiro Inositol Formula Designed for Women’s Daily Wellness Support
-
ViVi Youth Launches Advanced Myo-Inositol & D-Chiro Inositol Formula Designed for Women’s Daily Wellness Support
-
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
-
SALTO® by Case Systems Named Co-Presenting Sponsor of the Dow Championship STEM Center
-
ARCYN Defense Enters Cooperative Counter-Drone R&D Agreement With U.S. Army DEVCOM Armaments Center
-
PPG appoints John Smith to vice president, architectural coatings EMEA; Steve Pocock to retire
-
Oasis Chiropractic & Wellness Center Introduces Omniwave Shockwave Therapy For Musculoskeletal Conditions
-
City of Quincy and Cero Global Demonstrate Significant Emission Reductions and Cost Savings
-
DeFi Saver announces Reward program as part of Hyperliquid integration
-
CrowdHealth Unveils Bold New Program to Reverse Type 2 Diabetes
-
WiMi Explores Multi-Dimensional Pooling Optimization Technology under the Variational Quantum Algorithm Framework
-
V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform
-
One Independent Vision: 'The Madness of David Judge' Leads a Grassroots Charge into Emmy® Season
-
6lock Releases Inaugural Wire Fraud Report: Compliance Posture No Longer Protects PE Firms from Fiduciary Liability
-
BoodleBox Brings 100-Campus AI Implementation Insights to the Teaching and Learning with AI Conference
-
Metropolitan Dermatology Introduces Nevisense® Technology for Advanced Melanoma Detection
-
Ed O'Neill Joins David Faustino for Exclusive Married… with Children Bundy Club Reunion Event June 11
-
Gastesi Lopez Mestre & Cobiella Announces Partner Promotions for Ruth Acevedo and Jennifer M. Vazquez
-
Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today
-
ELEKTROS Evaluates Agentic Workflow Initiative for Small and Midsize Businesses Amid Rising Energy Costs
-
Koi Peptides Expands Research Catalog In June 2026
-
FinThrive Showcases Community Advantage with $4.8M Annual Value Delivered at Summit Healthcare
-
Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1
-
Eastern Union Secures $12,967,500 in Financing Toward Acquisition of 174,078-Square-Foot Shopping Center in Lima, Ohio
-
InfoHawk Raises $2.25M in Pre-Seed Funding to Detect and Prevent AI-Driven Deception and Scams
-
Subway® and Disney's Live-Action Moana Chart a Course with New Meal Deal and $15 off to See the Most Anticipated Movie of the Summer
-
Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security
-
AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment
-
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
-
Lifordi Immunotherapeutics Presents Phase 1 Clinical Data for LFD-200, a Subcutaneous Glucocorticoid Antibody Drug Conjugate, at EULAR 2026
-
BlueCollar Debuts AI-Powered Construction Management Software
-
Nex-Tech and Connectbase Strengthen Partnership to Support Connectivity Growth Between Kansas City and Denver
-
BrandPilot AI Converts Global Luxury Brand Trial into Ongoing Customer Engagement
-
SOL Strategies Reduces Debt Through Active Treasury Management
-
Homerun Resources Inc. Completes CAPEX Budget for the 3N Primary Silica Sand Purification Plant
-
Acclaimed Catskills Resort Hemlock Expands Its 'Adult Camp' Experience With New Adventures, Hobbies And Outdoor Activities
-
Rianka R. Dorsainvil, CFP® Joins BestFarewell as Strategic Advisor
-
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
-
Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth
-
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
-
As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Feat
-
QumulusAI to Participate in Maxim Virtual AI Data Center Conference
-
Noble Roman's Announces 2025 Financial Data and Other Highlights
-
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
-
Rocky Mountain Chocolate Factory to Participate in The Small Cap Showcase & WTR Insights Conference on June 9, 2026
-
LEIFRAS Co., Ltd. Commences School Club Activity Support Operations in Niiza City, Saitama Prefecture
